Mirae Asset Global Etfs Holdings Ltd. Galectin Therapeutics Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 4,388 shares of GALT stock, worth $5,660. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,388
Previous 11,705
62.51%
Holding current value
$5,660
Previous $13,000
61.54%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GALT
# of Institutions
103Shares Held
10.1MCall Options Held
587KPut Options Held
2.02M-
Vanguard Group Inc Valley Forge, PA2.19MShares$2.83 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$2.02 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.22MShares$1.58 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA853KShares$1.1 Million0.0% of portfolio
-
Geneos Wealth Management Inc.423KShares$545,9730.02% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $76.7M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...